Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01122
http://purl.obolibrary.org/obo/dinto_DB01122
|
|---|---|
| Preferred Name | ambenonium |
| Synonyms |
[(2-chlorophenyl)methyl](2-{[(2-{[(2-chlorophenyl)methyl]diethylazaniumyl}ethyl)carbamoyl]formamido}ethyl)diethylazanium
C28H42Cl2N4O2
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | ambenonium
|
|---|---|
| label | ambenonium
|
| DBSynonym | ambenonum
|
| ATCCode | N07AA30
|
| Definition | Ambenonium is a cholinesterase inhibitor used in the management of myasthenia gravis. [Wikipedia]
|
| has effect | |
| has pharmacological target | |
| inhibits | |
| type | |
| InChIKey | InChIKey=OMHBPUNFVFNHJK-UHFFFAOYSA-P
|
| Synonym | [(2-chlorophenyl)methyl](2-{[(2-{[(2-chlorophenyl)methyl]diethylazaniumyl}ethyl)carbamoyl]formamido}ethyl)diethylazanium
C28H42Cl2N4O2
|
| xref |
Wikipedia:http://en.wikipedia.org/wiki/Ambenonium
PubChem Compound:2131
National Drug Code Directory:0024-1287-04
ChEBI:2627
PubChem Substance:46508143
PharmGKB:PA164764601
ChemSpider:2046
Drugs.com:http://www.drugs.com/cdi/ambenonium.html
See more
See less
|
| CASRN | 7648-98-8
|
| prefixIRI | obo2:dinto_DB01122
|
| related with | |
| SMILES | CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl
|
| may interact with |
See more
See less
|
| InChI | InChI=1S/C28H40Cl2N4O2/c1-5-33(6-2,21-23-13-9-11-15-25(23)29)19-17-31-27(35)28(36)32-18-20-34(7-3,8-4)22-24-14-10-12-16-26(24)30/h9-16H,5-8,17-22H2,1-4H3/p+2
|
| DBBrand | mytelase
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |